Chest
Volume 108, Issue 3, September 1995, Pages 848-855
Impact of Basic Research on Tomorrow's MedicinePotential Therapeutic Initiatives for Fibrogenic Lung Diseases
Under a Creative Commons license
open archive
Key words
antioxidants
growth factors
pulmonary fibrosis
type I collagen
Cited by (0)
Supported by National Heart, Lung and Blood Institute grant P01HL-46902 and the Veterans Administration Merit Review Research Program. Dr. Fine is the recipient of the Dalsemer Research Scholar Award from the American Lung Association.
Copyright © 1995 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.